期刊
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
卷 107, 期 -, 页码 2580-2589出版社
ELSEVIER
DOI: 10.1016/j.ijbiomac.2017.10.143
关键词
MAP/microtubule affinity-regulating kinase; Citral: medicinal plants; Anticancer activity; Kinase inhibition assay; High-affinity ligands; Molecular dynamics simulation
资金
- Council of Scientific and Industrial Research
- Department of Science and Technology (DST), Government of India [EMR/2015/002372]
- DST
Microtubule affinity regulating kinase 4 (MARK4) is a member of AMP-activated protein kinase, found to be involved in apoptosis, inflammation and many other regulatory pathways. Since, its aberrant expression is directly associated with the cell cycle and thus cancer. Therefore, MARK4 is being considered as a potential drug target for cancer therapy. Here, we investigated the mechanism of inhibition of MARK4 activity by citral. Docking studies suggested that citral effectively binds to the active site cavity, and complex is stabilized by several interactions. We further performed molecular dynamics simulation of MARK4-citral complex under explicit water condition for 100 ns and observed that binding of citral to MARK4 was quite stable. Fluorescence binding studies suggested that citral strongly binds to MARK4 and thereby inhibits its enzyme activity which was measured by the kinase inhibition assay. We further performed MTT assay and observed that citral inhibits proliferation of breast cancer cell line MCF-7. This work provides a newer insight into the use of citral as novel cancer therapeutics through the MARK4 inhibition. Results may be employed to design novel therapeutic molecule using citral as a scaffold for MARK4 inhibition to fight related diseases. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据